Landos Biopharma Inc (LABP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | N/A | N/A | 9,808 |
| Marketable Securities | N/A | N/A | 40,157 |
| Receivables | N/A | N/A | 1 |
| Other current assets | 0 | 0 | 144 |
| TOTAL | $N/A | $N/A | $50,110 |
| Non-Current Assets | |||
| PPE Net | N/A | N/A | 571 |
| Other Non-Current Assets | 0 | 0 | 11 |
| TOTAL | $N/A | $N/A | $582 |
| Total Assets | $N/A | $N/A | $50,480 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 0 | 0 | 2,048 |
| Accrued Expenses | N/A | N/A | 978 |
| TOTAL | $N/A | $N/A | $3,026 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 0 | 0 | 73,037 |
| TOTAL | $N/A | $N/A | $73,037 |
| Total Liabilities | $N/A | $N/A | $76,063 |
| Shareholders' Equity | |||
| Common Shares | N/A | N/A | 63 |
| Retained earnings | N/A | N/A | -25,585 |
| Other shareholders' equity | 0 | 0 | -77 |
| TOTAL | $N/A | $N/A | $-25,583 |
| Total Liabilities And Equity | $0 | $0 | $50,480 |